Apart from this film, Alia also has exciting projects like Sanjay Leela Bhansalis Baiju Bawara, director Vasan Balas next and Brahmastra 2 in her kitty.For more news and updates, stay tuned to ETimes.
El 20 de julio de 2026, Jiangsu Hengrui Pharmaceuticals anunci que Ribupatide (HRS9531, conocido como KAI-9531 fuera de la Gran China), un agonista dual de los receptores GLP-1/GIP desarrollado de forma independiente por la compaa, obtuvo resultados positivos de primera lnea en un ensayo clnico de fase III realizado en pacientes chinos con diabetes tipo 2 sin tratamiento farmacolgico previo
O estudo dela, o SUSTAIN 6, era um estudo pr-comercializao, de no inferioridade, com objetivo de se descartar um intervalo de confiana que passasse o 1.8
Dosing plans with long holds and scheduled reviews were practically designed for this kind of moving target, and if you're also on hormone therapy, the two treatments deserve to be managed by the same brain